Inside BioNTech’s Transformation: From COVID-19 Vaccine Success to Battling Cancer with mRNA Innovation
BioNTech, known for its COVID-19 vaccine, is shifting focus to mRNA technology for cancer treatment. Vaccine revenue declines have led to significant financial losses, prompting the company to pursue oncology…